# A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute Pyelonephritis

> **NCT06144060** · PHASE2 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 126 (estimated)

## Conditions studied

- Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)

## Interventions

- **DRUG:** HRS -8427
- **DRUG:** Imipenem and Cilastatin Sodium

## Key facts

- **NCT ID:** NCT06144060
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12
- **Primary completion:** 2024-06
- **Final completion:** 2024-07
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06144060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06144060, "A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute Pyelonephritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06144060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*